Exploring the Role of Antidiabetic Medications in Lung Cancer Therapy: Clinical Insights and Potential Mechanisms - Top-Institutions - MDSpire

Exploring the Role of Antidiabetic Medications in Lung Cancer Therapy: Clinical Insights and Potential Mechanisms

  • By

  • Qian Wang

  • Jiayi Xu

  • Qing Liu

  • Haixia Zhou

  • Yue Hu

  • April 29, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Oncology
    • Molecular Medicine
    • Pharmacology

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology
    • Endocrinology
    • Translational Research

  • #3

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Oncology
    • Pharmacology
    • Endocrinology

  • #4

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Oncology
    • Endocrinology
    • Precision Medicine

  • #5

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology
    • Pharmacology
    • Clinical Trials

Original Source(s)

Exploring the Role of Antidiabetic Medications in Lung Cancer Therapy: Clinical Insights and Potential Mechanisms

  • by Qian Wang, Jiayi Xu, Qing Liu, Haixia Zhou, Yue Hu

  • April 29, 2026

Related Content

FEBAIR microsurgical principles in meningiomas and recurrence: a long-term follow-up series

Validation of a cervical CDO1/CELF4 methylation test for endometrial cancer: a prospective paired-sample comparison with intrauterine specimen

Stimuli-responsive nanoplatforms for sonodynamic immunotherapy: opportunities and challenges in cancer treatment